Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06633224 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

StatusRecruiting
PhaseNot specified
Started2024-12-27
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 5 months later Sep 1, 2026 → Feb 1, 2027
See other at-risk trials from University of California, San Francisco

Amendment history

2026-09-16
Primary completion pushed: 2026-09-01 → 2027-02-01
Completion pushed: 2027-09-01 → 2028-02-01
2025-09-09
Study Status, Eligibility v2
Eligibility criteria+28 characters
[...] .e., cancer systemic therapies or radiation therapy) in the past yearmonth except surgery or inductive Chemotherapy (CTX). Participants receiving >= 15 fractions. Participants is ma [...]
2025-01-22
Not Yet Recruiting→Recruiting Study Status, Eligibility, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2025-01-15→confirmed 2024-12-27
Eligibility criteria+40 characters
[...] pies or radiation therapy) in the past year except surgery. Participants receiving >= 15 fractions. Participants is male or female and is >18 years of age on th [...]
Study sitesdetails revised at 1 of 1 site
2024-10-07
Original filing
Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemotherapy and radiation therapy (CCRT) and to develop and assess predictive models for CRF severity.
Trial Details
NCT Number NCT06633224
Lead Sponsor University of California, San Francisco
Collaborators: National Cancer Institute (NCI)
Conditions Cancer, Thoracic Cancer, Gynecologic Cancer, Head and Neck Cancer, Gastrointestinal Cancer
Enrollment 125 participants
Start Date 2024-12-27
Primary Completion 2027-02-01 (estimated)
Study Completion 2028-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-09-15